JOURNAL OF PEDIATRIC INFECTION, cilt.6, sa.1, ss.1-5, 2012 (ESCI)
Objective: The aim of this multicentric prospective study was to evaluate the efficacy of a new bioequivalent formulation of oseltamivir for the treatment of influenza A, influenza B and H1N1 during the 2010-2011 influenza season.